News Focus
News Focus
Post# of 257253
Next 10
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

Re: NP1986 post# 125690

Monday, 10/03/2011 10:11:34 AM

Monday, October 03, 2011 10:11:34 AM

Post# of 257253
AZN in-licenses PFE’s tremelimumab for undisclosed amount:

http://finance.yahoo.com/news/MedImmune-InLicenses-Cancer-prnews-988614173.html?x=0&.v=1

…MedImmune will assume global development rights to tremelimumab and Pfizer will retain the rights to use tremelimumab with specified types of combination therapies. MedImmune plans to explore tremelimumab in a number of potential cancer indications. Terms of the agreement were not disclosed.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now